Tuberculosis transmission and progression are largely driven by social factors such as poor living conditions and poor nutrition. Increased standards of living and social approaches helped to decrease the burden of tuberculosis before the introduction of chemotherapy in the 1940s. Since then, management of tuberculosis has been largely biomedical. More funding for tuberculosis since 2000, coinciding with the Millennium Development Goals, has yielded progress in tuberculosis mortality but smaller reductions in incidence, which continues to pose a risk to sustainable development, especially in poor and susceptible populations. These at-risk populations need accelerated progress to end tuberculosis as resolved by the World Health Assembly in 2015. Eff ectively addressing the worldwide tuberculosis burden will need not only enhancement of biomedical approaches but also rebuilding of the social approaches of the past. To combine a biosocial approach, underpinned by social, economic, and environmental actions, with new treatments, new diagnostics, and universal health coverage, will need multisectoral coordination and action involving the health and other governmental sectors, as well as participation of the civil society, and especially the poor and susceptible populations. A biosocial approach to stopping tuberculosis will not only target morbidity and mortality from disease but would also contribute substantially to poverty alleviation and sustainable development that promises to meet the needs of the present, especially the poor, and provide them and subsequent generations an opportunity for a better future.
Introduction
Tuberculosis has been called the perfect expression of an imperfect civilisation. 1 Despite scientifi c and social advances a high burden of tuberculosis persists worldwide, particularly aff ecting poor and susceptible populations. 1 Tuberculosis transmission and progression are largely driven by social factors such as poor living conditions and poor nutrition.
2 However, with the discovery of anti-tuberculous medicines in the 1940s, the approaches in fi ghting tuberculosis have been largely biomedical. 3, 4 The burden of tuberculosis declined rapidly in the early 1950s, coinciding with the use of anti-tuberculous medicines, but progress since the 1960s has been slow and uneven, with declines in many settings occurring well before the introduction of chemotherapy (fi gure 1), probably attributable at least in part to improved standards of living. 2, 5, 6 In the late 1980s and early 1990s, when the HIV epidemic was emerging, funding was reduced for tuberculosis treatment programmes in many industrialised countries, and the Soviet Union was breaking up, 7-9 tuberculosis incidence and mortality rose to become the sixth leading cause of death worldwide, and the eighth leading cause of disease burden worldwide in 1990. 10, 11 In 1993, WHO declared tuberculosis a global health emergency, and in 1994, adopted a new approach to address tuberculosis called DOTS-originally an acronym for directly observed therapy, short course, but later used to identify the entire WHO-endorsed strategy including political commitment, drug supply chain management, and monitoring and assessment in addition to treatment using standard regimens. 12 However, worldwide tuberculosis incidence and mortality remained high throughout the 1990s. In 2000, the Millennium Development Goal 6: "combat HIV/ AIDS, malaria and other diseases", 13 and the creation of the Global Fund to Fight AIDS, Tuberculosis and Malaria in 2002 helped to mobilise new funding to fi ght the tuberculosis epidemic. 13 However, rates of tuberculosis incidence worldwide decreased more slowly than those for both HIV and malaria; estimates of the pace of decline in tuberculosis incidence since 2000 range from less than 1% per year to around 1·5% per year with variations by country and region. 5 Tuberculosis has its roots in underdevelopment, poverty, and social exclusion.
2 Slow progress in the fi ght against tuberculosis since the 1990s is due in part to gaps in coverage of DOTS programmes, 14 but more importantly
Key messages
• Tuberculosis has its roots in underdevelopment, poverty, and social exclusion, but worldwide eff orts to address tuberculosis during the past several decades have emphasised biomedical solutions.
• Progress against tuberculosis has been slow because of gaps in coverage of tuberculosis programmes and unmitigated risk factors for tuberculosis transmission and progression in low-income and middle-income countries, including overcrowding, indoor air pollution, malnutrition, diabetes mellitus, and tobacco and alcohol use.
• Social solutions for fi ghting tuberculosis, such as improved nutrition and improved housing conditions, were evidently major drivers of reductions in the burden of tuberculosis in the pre-chemotherapy era.
• The fi ght against tuberculosis should strengthen current biomedical solutions through new treatments, diagnostics, and service delivery models-and introduce approaches to combat the social drivers of the epidemic.
• Stopping tuberculosis needs a biosocial solution-one that integrates the social and biomedical approaches for sustainable development. Sustainable development aims to meet "the needs of the present without compromising the ability of future generations to meet their own needs". 25, 26 In practice, this statement means meeting basic needs (eg, food, shelter, and sanitation), while providing those in need with opportunities for a better quality of life through social, economic, and environmental action. Sustainable development promises to meet the needs of the poor and provide them an opportunity for a better future. The long history of tuberculosis and society's organised response to it can be instructive; social approaches to fi ghting tuberculosis, such as improved nutrition and social conditions, evidently contributed to reducing the burden of tuberculosis in the pre-chemotherapy era. The time has come to reconsider the fi ght against tuberculosis as a development imperative: a response that combines social approaches from the past with enhanced biomedical approaches that not only target morbidity and mortality from disease but also contribute to poverty alleviation and sustainable development.
The social approach of the past
Before the introduction of chemotherapy in the 1950s, solutions for tuberculosis were largely based on improving living standards or providing infected individuals with space, clean air, sunlight, rest, and proper nutrition, typically in sanatoria, which kept infected individuals isolated from the general public. 1 However, this method of treatment was expensive and largely inaccessible to poor populations that had disproportionally high rates of tuberculosis, prompting countries like Chile to introduce social approaches to managing tuberculosis (panel).
As working conditions in factories improved and public health interventions improving overall sanitation were implemented, the burden of tuberculosis began to decline in the rich and the poor. 1, 6 Economic prosperity enabled people to feed themselves properly and live in more spacious housing. McKeown, 6 who recognised the eff ect of improved standards of living on tuberculosis by analysing historic death records in England and Wales, argued that an improved diet was the greatest contributor to the tuberculosis decline.
The era of biomedical interventions
After the discovery of streptomycin in 1944, various anti-tuberculosis drugs emerged in the 1950s, leading to an era of combination therapy for treating active tuberculosis. However, the risk factors for infection largely remained the same. From 1960 to 1999 the world population grew at an unprecedented rate, increasing During the 1930s, Chile had the highest tuberculosis mortality burden of any country globally. Chile-fully aware of the social determinants for tuberculosis-devised a 14-point social reform to address the epidemic by reducing the country's underlying social inequalities and improving the living standards of the growing working class. 27 This social reform shifted the focus of the tuberculosis response from the individual patient (eg, sanatoria and surgical interventions) to the larger social context. Despite initial successes in decreasing deaths from tuberculosis in Chile through the 1940s, social reform was quickly replaced by biomedical solutions after the introduction of chemotherapy in the 1950s. from 3 billion to 6 billion. 28 Globalisation and new technologies increased the movement and spread of people, products, and information. Urbanisation accelerated, as people moved from rural areas to crowded cities in search of employment, but found all too often cramped living quarters, low wages, and poor working conditions, and struggled to aff ord adequate nutrition. In low-income and middle-income countries, absence of universal health coverage meant that many individuals seeking tuberculosis care could not aff ord health services. 29 The biomedical approach to management of tuberculosis likewise evolved over time. In 1994, WHO launched DOTS, emphasising standardised case manage ment of tuberculosis-to replace earlier approaches that involved many diff erent medicines for lengthy periods. DOTS-Plus followed in 1999, with the addition of culture-based diagnosis, drug susceptibility tests, and treatment with second-line drugs to DOTS to address the emerging burden of multidrug-resistant (MDR) tuberculosis. 30, 31 Persistent challenges in fi ghting tuberculosis prompted the launch of the Stop TB Strategy in 2006, which emphasised DOTS expansion, laboratory strengthening, tuberculosis with HIV, MDR tuberculosis, and the development of new methods. 24, 32 Although DOTS has undoubtedly contributed to the fi ght against tuberculosis since the 1990s, the biomedical approach has mainly emphasised supply-side interventions that rely heavily on functioning health systems. Yet tuberculosis remains deeply rooted in poverty and poor living conditions. Therein lies the diffi culty: a biomedical approach to fi ghting tuberculosis addresses only part of the issue. A biosocial model that combines biomedical and social approaches is crucial and well overdue to win the battle against tuberculosis.
Rediscovering and enhancing the social approach
Tuberculosis is both a cause and result of poverty, 23 driven by social exclusion, including malnutrition, overcrowding, and indoor air pollution.
2,17 Tuberculosis risk is higher in individuals facing other illnesses such as HIV and diabetes, and those participating in behaviours that put their health at risk, such as smoking and excessive use of alcohol.
2 The risk factors associated with poverty not only increase susceptibility to active tuberculosis, but are also associated with greater diffi culty in accessing care in health systems because of fi nancial and geographical constraints, and provider prejudices. 30 Limited access to the health system delays diagnosis and treatment of tuberculosis, leading to longer periods of infectiousness and greater mortality risk (fi gure 2).
Tuberculosis is a driver of poverty. The disease leads to days off work and out of pocket health expenditures. Around 60% of the fi nancial burden of tuberculosis comes from income loss when people are on treatment, and tuberculosis patients and their families spend an average of over half their yearly income on tuberculosis treatment. 30 The high cost of tuberculosis treatment makes it diffi cult for infected individuals to aff ord the full regimen of 6 or more months of therapy, impeding adherence and treatment success. 31 The result is a vicious tuberculosis-poverty cycle that cannot be broken by biomedical interventions alone (fi gure 2).
Our analysis strongly suggests substantial association between level of development (sanitation, improved water, access to electricity, urbanicity, malnutrition, and education), poverty, health system access, and tuberculosis (table) . Social interventions aimed at addressing tuberculosis must therefore address these pathways specifi cally and collectively in the tuberculosis-poverty cycle (fi gure 2). Social interventions can eff ectively combine with biomedical approaches that incorporate new technologies and solutions. Interventions in nutrition, urban planning and built environment, working conditions, addiction recovery, and psychological services hold much promise.
Social protection for tuberculosis risk
Social protection and health interventions have been combined to eff ectively address infectious diseases, as well as maternal and child health. 33 Social protection spending that allocates resources to elderly and susceptible populations, unemployment protection, and housing, is strongly associated with lower tuberculosis case notifi cations, incidence, and mortality rates. A study of 21 European countries showed between 1995 and 2012, each increase in social protection spending of US$100 per person was associated with a 1·5% decrease in the number of tuberculosis case notifi cations, 1·7% decrease in estimated tuberculosis incidence, 2·7% decrease in the rate of non-HIV-related tuberculosis mortality, and 3·2% decrease in the rate of all-cause mortality. 34 In Peru, education, community mobilisation, psychosocial support, and poverty reduction programmes improved tuberculosis screening from 82% to 96% and treatment completion from 91% to 97%. 35 Cash transfer schemes, both direct and indirect, and microfi nance can help benefi ciaries utilise health services and improve their health outcomes. 36 Increasing socioeconomic position, food security, and health-care access-all major protective factors for tuberculosiscan reduce the burden of both poverty and tuberculosis. 37, 38 Direct cash transfer can increase tuberculosis treatment completion rates and decrease default rates; a study from China 38 showed that individuals that received cash transfers had 8% higher treatment completion rates and 21% lower default rates compared with controls.
Enhancing nutritional value
The association between nutrition and tuberculosis is well established. 18, [39] [40] [41] [42] Malnutrition and micronutrient defi ciencies increase the risk of active tuberculosis, which in turn worsens malnutrition. Rapid urbanisation in low-income and middle-income countries is contributing to the nutritional transition that increases prevalence of diabetes, which amplifi es tuberculosis risk and worsens outcomes in those infected with tuberculosis. 29 In view of the connection between nutrition and tuberculosis, interventions such as nutritional counselling, food parcels, or high-energy oral nutritional supplements might enhance management of tuberculosis. 43 Micronutrient supplementation (eg, vitamin A-fortifi ed sweet potatoes) or food aid for susceptible or transient populations are population-level interventions that would help improve nutritional status and probably reduce risk of tuberculosis. 41, [44] [45] [46] Sustainable agricultural interventions include individual agricultural support and incentives for the growth of diversifi ed crops that are more economically viable in the long term than cash crops (which generate money more quickly) or use of high-yield seeds that are more robust to droughts, and are additional strategies that might shape agricultural practice in low-income and middle-income countries in a way that has a positive eff ect on tuberculosis and other health outcomes. 47 
Improving the built environment
Tuberculosis is spread via aerosol droplets from a patient with active disease. Overcrowding, indoor air pollution, and poor ventilation in homes, hospitals, and public transportation assist with the spread of the infection. 15, 29, 48 In low-income and middle-income countries, migration from rural to urban areas has led to an estimated 1 billion people living in overpopulated slum communities with poor infrastructure. From 1950 to 2014 the urban population grew from 746 million to 3·9 billion worldwide and by 2050 the UN projects that 66% of the world's population will live in urban areas 49, 50 with implications for the struggle against tuberculosis. Rapid urbanisation calls for better built environment and improved housing design in urban areas, 51 the development of policies controlling urbanisation, urban regeneration and slum upgrading programmes, and design of public spaces and transportation systems to reduce transmission risk at home or work, while commuting, and in public places. 52 Innovative technologies that improve local exhaust, general ventilation, room fi ltration, and ultraviolet air disinfection can promote natural ventilation and reduce transmission risk. 53 A study in rural South Africa 54 suggests that the risk of tuberculosis transmission decreased from 55·4% to 9·6% by opening windows and doors to increase airfl ow. Improving the built environment has benefi ts beyond direct health eff ects. Better roads, for example, improve access to schools, health services, and food markets, all of which can greatly reduce the burden of tuberculosis.
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Reducing occupational risk
Factory workers and labourers working in extractive industries such as mining are populations at greater risk for contracting tuberculosis. [55] [56] [57] In South Africa, the incidence of tuberculosis in miners is ten times higher than the general population and miners have 3·6 times Country-years of data refers to the sum of the number of countries, multiplied by the number of years of data used for each country in the analysis. The tuberculosis case notifi cation coeffi cient refers to the association between the case notifi cation rate, the dependent variable in the regression analysis, and the WDI for poverty and deprivation used in the analysis as an explanatory variable. To explore the relation between poverty indicators and tuberculosis outcome in the tuberculosis-poverty cycle (fi gure 2) we used WHO tuberculosis case notifi cations (corrected for under-reporting using case detection rates estimated from country workshops) and World Bank WDIs. The WDI variables included in our analysis were intended to capture living conditions (eg, sanitation, improved water source access, access to electricity), nutrition, education, out of pocket health expenditure, and health system access (measured by DPT immunisation). We also included the World Bank's composite poverty indicators as a measure of income inequality. The analysis consisted of 11 separate mixed-eff ect regressions with random eff ect on country. Each regression quantifi ed the association between the tuberculosis case notifi cation rates with one of the WDI variables. Country random eff ects were included to control for dependence of reported observations over time within the same country, and calendar year was included as an additional independent variable to control for share of secular trends in tuberculosis case notifi cation rates across countries. The regression results support the associations outlined in the tuberculosis-poverty cycle; all the regression coeffi cients are signifi cant (p<0·05) with the exception of education and health-care expenditure, and all coeffi cients have the expected sign. Improved living conditions, health system access, and education have a negative relationship with tuberculosis case notifi cation rates, and increased malnutrition, health expenditure, poverty, and inequality have a positive relationship with tuberculosis case notifi cation rates. DPT=diphtheria, pertussis, and tetanus. WDI=World Development Indicator.
Table: Tuberculosis case notifi cation rates and World Development Indicators of poverty and deprivation
greater odds of dying from tuberculosis compared with other workers in the region. 58, 59 Miners, who are in poorly paid and demanding jobs, typically work and live in congregate settings with poor ventilation and indoor air pollution. Factory workers and labourers are often migrants, spreading the infection from work to their home towns. Good employment practices (including appropriate wages, reasonable hours, health insurance, and protection from injury), decent conditions at the workplace, and living accommodations aimed at the "Declaration on Tuberculosis in the Mining Sector" by the 15 heads of state belonging to the Southern African Development Community, can greatly reduce risk of tuberculosis in working populations, especially those working in extractive industries.
60
Improving mental health
Mental illness often prevents individuals from properly caring for themselves, contributing to malnutrition and a weakened immune system, and increasing the risk of developing active tuberculosis infection. 61 Additionally, mental illness hampers adherence to medical care, which reduces the eff ectiveness of tuberculosis treatment. Mental illness carries stigma and is strongly associated with homelessness, 62 making it diffi cult for individuals to secure employment. The relation between mental health and tuberculosis likewise works in reverse-mental illness develops or is worsened by social isolation during treatment or can emerge as a side-eff ect of some treatment drug regimens, all compounded by the stigma for mental illness and tuberculosis alike. 61 Psychological services and housing assistance for tuberculosis patients can help improve health outcomes and provide these individuals with an opportunity to plan for their future. 63 Individuals with mental health disorders are at greater risk for addictive disorders, particularly alcohol misuse. 64 Alcohol use is a risk factor for the development of active tuberculosis; people who drink more than 40 g of alcohol a day are around three times more likely to develop tuberculosis compared with those who do not. 65 
Enhancing the biomedical approach
Although many of the technological components of the approach to preventing, diagnosing, and treating tuberculosis are decades old, there is renewed interest in developing new diagnostics, drugs, and treatment regimens. 66 As potential new products are developed, it remains essential to consider whether innovations in delivery of existing interventions can greatly reduce the burden of tuberculosis.
Developing eff ective vaccines
Limitations in available tuberculosis vaccines and treatment regimens have been well characterised. [67] [68] [69] [70] [71] [72] [73] The BCG vaccine was developed in the 1920s and estimates of its eff ectiveness have ranged from 80% protection to no benefi t, 74, 75 with particular concerns about duration of protection and therefore subsequent population-level eff ects in terms of preventing active tuberculosis in adolescents and adults. Although there continues to be high interest in developing new tuberculosis vaccines, development of a novel tuberculosis vaccine with high effi cacy and persistent protection remains an elusive goal.
67-70
Developing new treatment approaches
For individuals with latent Mycobacterium tuberculosis infection, preventive treatment can be eff ective in reducing the likelihood of progression to active disease. 76 Commonly recommended preventive therapy regimens have durations up to 9 months, but more recent studies have reported that shorter regimens can provide similar effi cacy. 69, 70 For active cases of tuberculosis, standard fi rst-line treatment regimens continue to be based on drugs that were discovered 50 to 60 years ago, and there are various challenges associated with these therapies, including long treatment durations, toxic eff ects, interactions with antiretroviral drugs, and drug resistance in some settings. 71 Several new options are in various stages of development, with the potential to shorten regimens, yield high effi cacy against MDR tuberculosis, and provide eff ectiveness against both latent and active tuberculosis.
72,73
Improving tuberculosis detection
A rapid and accurate point-of-care diagnostic test for tuberculosis is still absent, therefore detection of tuberculosis is highly reliant on individuals accessing the health system. 77 Tuberculosis prevalence surveys 78 have shown that more than 50% of those with bacteriologically confi rmed tuberculosis do not report the symptoms that often trigger disease investigation (eg, cough lasting 2-3 weeks). WHO reports that in 2013 more than 3 million tuberculosis cases worldwide were undiagnosed or were not notifi ed. Case detection in many settings continues to rely largely on sputum smear microscopy, which has low sensitivity, especially in HIV-infected patients, and can cause delays in initiating treatment or loss to follow-up because immediate results are not available. However, alternative choices are becoming available, with potential to off er substantial improvements in test characteristics. 79 An important advance in tuberculosis diagnosis was the introduction of the Xpert MTB/RIF test, with greater sensitivity than sputum smear microscopy, leading to 45% increase in case detection in patients infected with HIV. 80, 81 The experience with implementing Xpert substantiated the benefi ts of better case detection with new diagnostics, and highlighted the challenges in introducing new technologies in weak health systems with poor service coverage and access. 82 
Treatment with mobile telephone and health information technologies
Mobile telephone messaging is eff ectively used for managing self-management of long-term illnesses. 83 SMS text messaging improves treatment adherence and success of tuberculosis treatment. 84 A study done in South Africa 84 reported that tuberculosis cure rates were 2·3 times higher in patients that received SMS reminders for treatment compared with another group receiving standard DOTS treatment, whereas a study in Kenya 84 reported clinical attendance on scheduled days was 1·56 times higher in tuberculosis patients that received SMS reminders compared with those who did not. Electronic health records, including open source systems, mobile telephones, or personal digital assistants could be used to track and monitor patients with tuberculosis to improve health outcomes, as has been shown in Africa (Kenya, Rwanda, South Africa), Latin America (Peru), and Asia (Philippines).
85,86
Combining biomedical and biosocial approaches
The enhanced social and biomedical approaches to tuberculosis care are not mutually exclusive, but can work together to address tuberculosis, especially in hard to reach and at-risk populations, and promote sustainable develop ment. Although addressing the social determinants through a biosocial approach helps to reduce tuberculosis burden and improve outcomes, an enhanced biomedical approach could help reduce poverty and improve life chances of aff ected individuals and families, thereby improving their social determinants of health.
Tuberculosis places a disproportional burden on particular at-risk groups such as migrants and refugees, 46 individuals living in densely populated urban areas or living in areas of confl ict and crisis, 15, 29, 45, 48, 52 children, and individuals with HIV/AIDS or diabetes. Understanding the context and developing context-specifi c solutions is important, as tuberculosis propagates through a series of local outbreaks, and the local conditions aff ect the success of tuberculosis programmes. 7, 9, 87 Societal upheavals can displace large populations to new environments that lack food, adequate housing, and medical care, and increase the risk of mental illness, all of which are risk factors for tuberculosis. In the USA, the percentage of tuberculosis cases occurring in foreign-born people is over 60%. 88 As a result of the Ebola crisis, several tuberculosis programmes in Liberia, Guinea, and Sierra Leone were repurposed to address Ebola, leaving new and existing patients without treatment. 89 The health, social, and economic eff ect of tuberculosis on children is signifi cant; almost 1 million children have tuberculosis and 10 million children have been orphaned by tuberculosis. Children with tuberculosis are often in the hospital for extended periods of time, resulting in high treatment costs or parental lost time from work. 90, 91 Individuals with HIV/AIDS or diabetes have suppressed immune systems that make them more susceptible to the development of active tuberculosis. A biosocial approach to tuberculosis needs to be uniquely tailored to address at-risk populations and ensure context specifi city, taking into account cultural nuances and pervasive stigma.
Discussion
Sustainable development is predicated on meeting basic needs, eg, food, shelter, and sanitation, through social, economic, and environmental actions that are crucial for better quality of life and in the fi ght against tuberculosis. 25, 26 A biosocial approach that expands the biomedical model and combines it with social, economic, and environmental actions is essential for the fi ght against tuberculosis.
Biomedical approaches alone have not achieved substantial decreases in tuberculosis burden. Although expanding universal health coverage will improve access to essential health services and protect from catastrophic health expenditures, it alone will not be suffi cient to stop tuberculosis, as social determinants greatly aff ect the burden of tuberculosis, the fi ght against tuberculosis and the tuberculosis-poverty cycle. Evidence from Vietnam, Morocco, Pakistan, Sri Lanka, Myanmar, and India suggest that the benefi ts of improved diagnostics and treatment is off set by susceptibility to tuberculosis in at-risk populations. [92] [93] [94] Although the thrust of this Series paper is on biosocial approaches, we also argue for enhancing biomedical approaches by strengthening health systems and scaling up innovations in tuberculosis detection and treatment. Combining biomedical and biosocial approaches will allow cooperation in detection and treatment of tuberculosis, and address comorbidities (such as HIV and diabetes) and risks through social protection and improvements in nutrition, the built environment, occupational safety, and mental health.
Tuberculosis both causes and results from weak or failing health, education, and economic systems and development. Tuberculosis takes a heavy toll, not only on health and social services, but also on entire regions participating in the global economy, as tuberculosis predominantly aff ects the most economically active age group. An ailing workforce reduces productivity, lowers revenue, and weakens economies. By trapping people in a cycle of poverty and disease, tuberculosis slows national development and reduces competitiveness. 95 Combined biomedical and biosocial approaches are essential to mitigate the adverse eff ects of tuberculosis on individuals, households, and economies.
Implementing a biosocial approach to stop tuberculosis will be challenging, as the risk factors for tuberculosis will rise in the future. The number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030, 96 an estimated 70% of the world population could be living in urban areas by 2050, 97 the number of people living in slum dwellings will more than double to 2 billion in 2030 from 924 million in 2001, and worldwide migration will increase, with adverse risks for development. 98 A proposed biosocial approach will align the tuberculosis response with sustainable development goals, extending the responsibility for national tuberculosis strategies beyond the health sector. Successful implementation of a biosocial model will need shared vision and collaboration across government sectors, professional groups, and civil society to mount integrated multisectoral action. Leadership and political commitment at the highest level of government is essential to include ministries of fi nance, development, housing, labour, education, and health to compre hensively address the social, environmental, nutritional, and occupational risk factors for tuberculosis and monitor progress. 60 Just as food security is often used to assess the success of the nutritional eff ect of poverty reduction strategies, 99 tuberculosis indicators could be used to monitor the eff ect of poverty reduction, urban planning, and development strategies on health. Accountability for the tuberculosis response across sectors could be further amplifi ed through targets that relate to sectoral contributions to the tuberculosis response, such as the proportion of well aerated houses in public housing projects.
International institutions, such as the WHO, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Stop TB Partnership, UNAIDS, UNICEF, and the World Bank, have an important part to play, as they have done with the HIV response, to support country-led initiatives aimed at introducing the biosocial approach.
In addition to government and international organi sations, the private sector, non-governmental organisations, and civil society will be instrumental in targeting social, economic, and environmental tuberculosis risks. For instance, companies employing workers who face high tuberculosis risks either because of the nature of the occupation or socioeconomic characteristics (eg, low wage or seasonal workers), 23, [55] [56] [57] can contribute to biosocial approach through targeted prevention programmes. Similarly, labour unions and professional organisations, for example those in the mining, healthcare, and building industries, could contribute to the fi ght against tuber culosis-for example, by making sure their members are aware of approaches that reduce tuberculosis transmission risks through better design and building of public housing, schools, social spaces, and hospitals.
Introduction and scaling up of innovations for tuberculosis prevention, detection, and treatment, although crucial, might be hindered because of low rewards for innovators and commercial investors, 100 inability of governments to invest in new health technologies while coverage of other cost-eff ective health interventions are low, and the diffi culty for patients (who are typically the economically worst-off populations), to pay for novel tuberculosis interventions. Innovative approaches are needed to motivate the private and public sectors to invest in tuberculosis related research and development. Innovative fi nancing that has been used to fund product development partnerships, provide advance market commitments, establish patent pools for new medicines, and encourage rapid uptake of new diagnostics, treatments, and care models to address health priority interventions would be instructive to create incentives for innovations to address tuberculosis. 101 However, an important lesson from large-scale implementation of Xpert in South Africa, is that technological innovations can fail to achieve their potential eff ect because of health system barriers to implementation, such as access to services, paucity of human resources, or inappropriate infrastructure. 81 We have to learn from the past to create eff ective solutions for the future. Before the introduction of chemotherapy, the burden of tuberculosis was already decreasing as a result of social interventions and rising standards of living. Although biomedical interventions have helped to augment this decline, the improvements have been slow, and tuberculosis remains a major challenge worldwide. Stopping tuberculosis will need a renewed focus on multisectoral action to forge a biosocial response. The sustainable development agenda provides the opportunity to harness social, economic, and environmental actions to stop tuberculosis that has proven so diffi cult to defeat with biomedical approaches alone.
